Major Study Finds Steroid Reduces Deaths in Patients With Severe COVID-19

June 19, 2020 by Christen Aldrich

Filed under COVID-19 for Employers, COVID-19 for the Workforce

Last modified June 22, 2020

According to an article by Stat News, a large study has found that a cheap, readily available steroid drug reduced deaths by a third in patients hospitalized with COVID-19. This is the first time a therapy has been shown to possibly improve the odds of survival with the condition in the sickest patients.

In a statement, Patrick Vallance, the U.K. government’s chief scientific adviser, called the result “tremendous news” and “a ground-breaking development in our fight against the disease.” Scott Gottlieb, a former commissioner of the U.S. Food and Drug Administration, called it “a very positive finding” in an interview on CNBC. “I think it needs to be validated, but it certainly suggests that this could be beneficial in this setting.”

Share this

Related Articles

                                Leave a Comment